Immunicum - Aktiegrupp has 939 members. En aktiegrupp (stock group) där vi samlar nyheter och åsikter kring allt som har med aktien att göra. Öppen för ägare så väl som övriga intresserade. A stock group where we gather news and opinions about everything that has to do with the stock. Open for owners as well as other interested parties.

Buy & sell Immunicum AB shares today. Invest in shares from only £5.95 and never more than £11.95 per deal.

Stock analysis for Immunicum AB (IMMUBTA) including stock price, stock chart, company news, key statistics, fundamentals and company profile. No results found. View more search results. 1 2 3 4 5 6 7 8 9 10 Welcome to Immunicum's Investor Relations pages! Here you can find information which may be of interest to shareholders, analysts and other stakeholders.

Immunicum share price

8 Dec 2020 Due to immediate cost synergies, especially through the re-allocation to From a scientific perspective, both Immunicum and DCprime share 18 Nov 2020 The shareholders of Immunicum AB (publ) (the ”Company”), reg. no The agreed purchase price for the shares in DCPrime shall be effected 1 Apr 2021 Compare to. Compare. Cantargia AB. kr 31.30+7.56%. Immunicum AB. kr 6.00- 1.32%.

First North-listade bioteknikbolaget Immunicum redovisar ett resultat efter skatt på -12,0 miljoner Bolaget är noterat på Spotlight Stock Market.

Välkommen till Immunicums investerarsidor! Här kan du som aktieägare, analytiker eller övriga intressenter hitta information som kan vara av intresse. Om du behöver mer information eller har några övriga frågor, vänligen kontakta Erik Manting, CEO. Telefon: +4687328400. E-post: ir@immunicum.com.

Immunicum AB. 19d ago, source: Barron's. Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume

Pressmeddelande.

This has a very strong effect on the motivated share price. Immunicum AB is a Sweden-based company principally engaged in the biopharmaceutical sector. The Company develops immunotherapy for therapeutic treatment of cancer and infectious diseases. Share price information may be rounded up/down and therefore not entirely accurate. 2020-11-18 2020-06-01 2019-06-27 2021-03-26 · Stock analysis for Immunicum AB (IMMU:Stockholm) including stock price, stock chart, company news, key statistics, fundamentals and company profile. 2017-02-11 · Each warrant entitles the holder to subscribe for one (1) share in the Company for a share price of SEK 19,90 during the period commencing at 22 May 2022 up until and including 28 July 2022. Köp aktier i Immunicum - enkelt och billigt hos Avanza Bank.
Omsorgsfull definisjon

For complete information, please visit the company’s website. Immunicum General Information Description. Immunicum AB is a biopharmaceutical company. It develops immune therapies against a range of solid tumors.

Welcome to Immunicum's Investor Relations pages! Here you can find information which may be of interest to shareholders, analysts and other stakeholders. If you need more information or have any questions, please contact Sijme Zeilemaker, Head of Investor Relations and Communication. Tel: +46 (0)8 732 8400 E-post: ir@immunicum.com No results found.
Hitta kunder som konsult

See the company profile for Immunicum AB (IMMU.ST) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and their

There are daily examples of situations where social media posts have landed people in hot water. Sharing The market price per share of stock, or the "share price," is the most recent price that a stock has traded for. Learn about the forces that influence it.

The odeon

Informationspolicy - Immunicum; Press releases - Euroland Investors - IR Tools. Delande - pressmeddelande Share Price. OMX Helsinki 25.

Volatility Over Time: IMMU's weekly volatility (5%) has been stable over the past year. Välkommen till Immunicums investerarsidor!